Structured evidence table for Saffron Stress Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Saffron Stress Meta-Analysis | Background and aim Interest of herbal supplements as alternatives to conventional treatments for erectile dysfunction (ED) has increased markedly. | 1 | Ho CY (2025) | Herbal dietary supplements for erectile dysfunction: A systematic review and meta-analysis of randomized-controlled trials. |
| Saffron Stress Meta-Analysis | Results and conclusion Fourteen RCTs with a total of 1227 males with ED were included. | 1 | Ho CY (2025) | Herbal dietary supplements for erectile dysfunction: A systematic review and meta-analysis of randomized-controlled trials. |
| Saffron Stress Meta-Analysis | In contrast, evidence for other agents such as Tribulus terrestris and Maca remains insufficient, underscoring the need for larger, high-quality trials with longer follow-up. | 1 | Ho CY (2025) | Herbal dietary supplements for erectile dysfunction: A systematic review and meta-analysis of randomized-controlled trials. |
| Saffron Stress Meta-Analysis | This systematic review and meta-analysis aimed to evaluate the effectiveness of herbal supplements in treating ED. | 1 | Ho CY (2025) | Herbal dietary supplements for erectile dysfunction: A systematic review and meta-analysis of randomized-controlled trials. |
| Saffron Stress Meta-Analysis | This literature review synthesises evidence from randomised controlled trials, meta-analyses, safety data, dosing patterns, proposed mechanisms, and guideline positioning regarding saffron in depression, with a focus on adult major depressive disorder and related depressive symptomatology. | 4 | Dimech L (2026) | The Role of Saffron in the Treatment of Depression: A Literature Review. |
| Saffron Stress Meta-Analysis | Across placebo-controlled trials in mild-to-moderate depression, saffron, most commonly administered at 30 mg per day for approximately six weeks, has been associated with clinically meaningful reductions in depressive symptom severity, typically measured using the Hamilton Depression Rating Scale (HAM-D). | 4 | Dimech L (2026) | The Role of Saffron in the Treatment of Depression: A Literature Review. |
| Saffron Stress Meta-Analysis | Meta-analytic evidence generally indicates superiority over placebo and similar efficacy to selective serotonin reuptake inhibitors (SSRIs), with an overall favourable short-term tolerability profile; however, confidence is constrained by small sample sizes, restricted settings, variable product standardisation (including stigma versus petal preparations), and risk of bias/publication bias. | 4 | Dimech L (2026) | The Role of Saffron in the Treatment of Depression: A Literature Review. |
| Saffron Stress Meta-Analysis | Saffron ( Crocus sativus L.) has attracted increasing interest as a nutraceutical option for depressive disorders, particularly for patients who experience incomplete response or poor tolerability with conventional treatments. | 4 | Dimech L (2026) | The Role of Saffron in the Treatment of Depression: A Literature Review. |
Source documents